Itau Unibanco Holding S.A.’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.7K | Sell |
2,436
-6
| -0.2% | -$157 | ﹤0.01% | 278 |
|
|
2026
Q1 | $68.6K | Buy |
2,442
+82
| +3% | +$2.18K | ﹤0.01% | 222 |
|
|
2025
Q4 | $58.8K | Buy |
2,360
+672
| +40% | +$16.9K | ﹤0.01% | 238 |
|
|
2025
Q3 | $43K | Sell |
1,688
-6
| -0.4% | -$148 | ﹤0.01% | 264 |
|
|
2025
Q2 | $41.1K | Sell |
1,694
-26
| -2% | -$606 | ﹤0.01% | 277 |
|
|
2025
Q1 | $44K | Sell |
1,720
-500,000
| -100% | -$13.1M | ﹤0.01% | 282 |
|
|
2024
Q4 | $13.3M | Buy |
+501,720
| New | +$13.6M | 0.41% | 43 |
|
|
2023
Q4 | – | Sell |
-3,757
| Closed | -$125K | – | 489 |
|
|
2023
Q3 | $125K | Buy |
3,757
+273
| +8% | +$9.65K | 0.01% | 180 |
|
|
2023
Q2 | $128K | Sell |
3,484
-509
| -13% | -$19.8K | 0.01% | 210 |
|
|
2023
Q1 | $163K | Sell |
3,993
-5,893
| -60% | -$255K | 0.01% | 191 |
|
|
2022
Q4 | $507K | Sell |
9,886
-4,039
| -29% | -$194K | 0.02% | 153 |
|
|
2022
Q3 | $609K | Sell |
13,925
-75,433
| -84% | -$3.67M | 0.02% | 145 |
|
|
2022
Q2 | $4.68M | Buy |
89,358
+84,960
| +1,932% | +$4.33M | 0.16% | 79 |
|
|
2022
Q1 | $228K | Sell |
4,398
-4,878
| -53% | -$253K | 0.01% | 209 |
|
|
2021
Q4 | $542K | Buy |
9,276
+2,541
| +38% | +$126K | 0.02% | 129 |
|
|
2021
Q3 | $290K | Buy |
6,735
+4,498
| +201% | +$199K | 0.02% | 137 |
|
|
2021
Q2 | $88K | Buy |
+2,237
| New | +$87K | ﹤0.01% | 142 |
|
|
2020
Q2 | – | Sell |
-4,419
| Closed | -$137K | – | 354 |
|
|
2020
Q1 | $137K | Buy |
+4,419
| New | +$151K | 0.01% | 105 |
|
|
2019
Q4 | – | Sell |
-10,818
| Closed | -$385K | – | 957 |
|
|
2019
Q3 | $443K | Sell |
10,818
-10,606
| -50% | -$386K | 0.02% | 119 |
|
|
2019
Q2 | $879K | Buy |
21,424
+17,615
| +462% | +$699K | 0.04% | 116 |
|
|
2019
Q1 | $155K | Hold |
3,809
| – | – | 0.01% | 241 |
|
|
2018
Q4 | $155K | Sell |
3,809
-6,179
| -62% | -$257K | 0.01% | 241 |
|
|
2018
Q3 | $418K | Sell |
9,988
-5,179
| -34% | -$199K | 0.02% | 134 |
|
|
2018
Q2 | $522K | Sell |
15,167
-25,019
| -62% | -$855K | 0.06% | 101 |
|
|
2018
Q1 | $1.35M | Sell |
40,186
-22,000
| -35% | -$756K | 0.01% | 99 |
|
|
2017
Q4 | $2.14M | Buy |
62,186
+33,737
| +119% | +$1.15M | 0.13% | 53 |
|
|
2017
Q3 | $3.05M | Buy |
28,449
+26,288
| +1,216% | +$845K | 0.21% | 51 |
|
|
2017
Q2 | $69K | Buy |
2,161
+959
| +80% | +$30.2K | 0.01% | 261 |
|
|
2017
Q1 | $39K | Buy |
+1,202
| New | +$37.9K | ﹤0.01% | 259 |
|
Other funds holding PFE
Itau Unibanco Holding S.A.'s PFE Position: Q2 2026 in Review
Itau Unibanco Holding S.A. reduced its Pfizer (PFE) stake by 0.25% in Q2 2026, selling an estimated $157 and leaving 2,436 shares worth $58.7K. The position accounts for ﹤0.01% of the portfolio, ranked #278.
Itau Unibanco Holding S.A. first reported a position in PFE in Q1 2017 and has held it in 29 quarters since. The position peaked at $13.3M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Itau Unibanco Holding S.A. held 2,436 shares of Pfizer worth $58.7K as of Q2 2026.
- Itau Unibanco Holding S.A. sold 6 Pfizer shares in Q2 2026, an estimated $157.
- Pfizer made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #278 holding.
- Itau Unibanco Holding S.A. first reported a position in Pfizer in Q1 2017 and has held it in 29 quarters since.
- Itau Unibanco Holding S.A.'s Pfizer position peaked at $13.3M in Q4 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.